Cantor Fitzgerald upgraded CVS Health (CVS) to Overweight from Neutral.Maximize Your Portfolio with Data Driven Insights:Leverage the power of ...
As previously reported, Cantor Fitzgerald upgraded CVS Health (CVS) to Overweight from Neutral with a price target of $71, up from $62, citing ...
CVS Health beat Wall Street estimates for fourth-quarter profit on Wednesday and provided an annual forecast that largely met ...